These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 22153794

  • 1. Correlation of low SLC22A18 expression with poor prognosis in patients with glioma.
    Chu SH, Ma YB, Feng DF, Zhang H, Zhu ZA, Li ZQ, Jiang PC.
    J Clin Neurosci; 2012 Jan; 19(1):95-8. PubMed ID: 22153794
    [Abstract] [Full Text] [Related]

  • 2. Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma.
    Wang L, He S, Tu Y, Ji P, Zong J, Zhang J, Feng F, Zhao J, Gao G, Zhang Y.
    J Clin Neurosci; 2013 Jul; 20(7):958-63. PubMed ID: 23707602
    [Abstract] [Full Text] [Related]

  • 3. Decreased expression of NDRG2 is related to poor overall survival in patients with glioma.
    Li W, Chu D, Chu X, Meng F, Wei D, Li H, Sun B.
    J Clin Neurosci; 2011 Nov; 18(11):1534-7. PubMed ID: 21872476
    [Abstract] [Full Text] [Related]

  • 4. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
    Zagzag D, Blanco C, Friedlander DR, Miller DC, Newcomb EW.
    Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
    [Abstract] [Full Text] [Related]

  • 5. Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis.
    Shen A, Wang Y, Zhao Y, Zou L, Sun L, Cheng C.
    Neurosurgery; 2009 Jul; 65(1):153-9; discussion 159-60. PubMed ID: 19574837
    [Abstract] [Full Text] [Related]

  • 6. Downregulation of PCDH9 predicts prognosis for patients with glioma.
    Wang C, Yu G, Liu J, Wang J, Zhang Y, Zhang X, Zhou Z, Huang Z.
    J Clin Neurosci; 2012 Apr; 19(4):541-5. PubMed ID: 22300792
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
    He J, Deng Y, Yang G, Xie W.
    J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Stratifin expression is a novel prognostic factor in human gliomas.
    Deng J, Gao G, Wang L, Wang T, Yu J, Zhao Z.
    Pathol Res Pract; 2011 Nov 15; 207(11):674-9. PubMed ID: 21940111
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
    Lai NS, Dong QS, Ding H, Miao ZL, Lin YC.
    J Clin Neurosci; 2014 May 15; 21(5):755-60. PubMed ID: 24382515
    [Abstract] [Full Text] [Related]

  • 11. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
    Heimberger AB, McGary EC, Suki D, Ruiz M, Wang H, Fuller GN, Bar-Eli M.
    Clin Cancer Res; 2005 Jan 01; 11(1):267-72. PubMed ID: 15671555
    [Abstract] [Full Text] [Related]

  • 12. Downregulation of N-Myc downstream-regulated gene 4 influences patient survival in gliomas.
    Li S, Yang B, Li G, He S, Li Y.
    Brain Tumor Pathol; 2013 Jan 01; 30(1):8-14. PubMed ID: 22399192
    [Abstract] [Full Text] [Related]

  • 13. Identification of microRNA-205 as a potential prognostic indicator for human glioma.
    Hou SX, Ding BJ, Li HZ, Wang L, Xia F, Du F, Liu LJ, Liu YH, Liu XD, Jia JF, Li L, Wu ZL, Zhao G, Zhang ZG, Deng YC.
    J Clin Neurosci; 2013 Jul 01; 20(7):933-7. PubMed ID: 23683741
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Potential role of Jun activation domain-binding protein 1 and phosphorylated p27 expression in prognosis of glioma.
    He SM, Zhao ZW, Wang Y, Zhao JP, Wang L, Hou F, Gao GD.
    Brain Tumor Pathol; 2012 Jan 01; 29(1):3-9. PubMed ID: 21837501
    [Abstract] [Full Text] [Related]

  • 18. Expression of cell cycle regulator p27Kip1 is correlated with survival of patients with astrocytoma.
    Mizumatsu S, Tamiya T, Ono Y, Abe T, Matsumoto K, Furuta T, Ohmoto T.
    Clin Cancer Res; 1999 Mar 01; 5(3):551-7. PubMed ID: 10100706
    [Abstract] [Full Text] [Related]

  • 19. Over-expression of neuroepithelial-transforming protein 1 confers poor prognosis of patients with gliomas.
    Tu Y, Lu J, Fu J, Cao Y, Fu G, Kang R, Tian X, Wang B.
    Jpn J Clin Oncol; 2010 May 01; 40(5):388-94. PubMed ID: 20304779
    [Abstract] [Full Text] [Related]

  • 20. Ezrin expression in tissue microarray of primary and recurrent gliomas.
    Tynninen O, Carpén O, Jääskeläinen J, Paavonen T, Paetau A.
    Neuropathol Appl Neurobiol; 2004 Oct 01; 30(5):472-7. PubMed ID: 15488023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.